Tag: Insilico Medicine
Insilico nominates an AI-designed obesity pill with a safety edge
The Hong Kong-listed biotech used its generative chemistry platform to design ISM1354, a small-molecule GIPR antagonist built for obesity and…
AI-designed lung drug tilts aging clocks younger in trial data
Insilico says rentosertib, its AI-built IPF candidate, shifted six proteomic aging clocks toward younger profiles in a 12-week trial analysis.
Insilico’s compact MMAI models outdo dedicated drug discovery tools
Insilico's MMAI Gym specialist models post winning scores across drug discovery benchmarks.
AI-discovered drugs still need a human name on the patent
US patent law still demands a human inventor even when AI did the creative work.
Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
Insilico and Bora Pharma bring generative AI to drug manufacturing
The alliance extends Insilico's PandaOmics and Chemistry42 platforms into pharmaceutical manufacturing for the first time, targeting a $168B CDMO industry.